Brian F. Chapin
banner
chapinmd.bsky.social
Brian F. Chapin
@chapinmd.bsky.social
Urologic Oncologist focusing on high risk and advanced prostate cancer. Prof of Urology at MDACC by way of Siena, Gtown, MGH.
90% is generous. More like 80%
December 13, 2024 at 7:17 PM
I don’t think the implication is that you have the secret in your pocket, but rather that’s their way of asking if this is the right choice for them? Affirmation = comfort. I flip it around + discuss how each individual will have a different threshold of risk. And try to help them define theirs.
November 30, 2024 at 1:05 PM
We did it for the last 12 years in Houston but the Turkey Trot hosted by Baker Ripley is no more.
November 29, 2024 at 3:10 PM
Great comments here. Sensitivity of rhPSMA is ⬇️ but likely due to population included as cN+ were ineligible
4 the study. Dec’d Prevalence of the population leads to lower demonstrated sensitivity.
*COI: co-PI for BED studies.
Can’t be stated enough that a Neg PET doesn’t = absence of pN+ nodes.
November 29, 2024 at 3:03 PM
You boys look good in green.
November 22, 2024 at 10:46 PM
Not doing TURBTs but seems intriguing.
November 21, 2024 at 1:52 AM
November 20, 2024 at 2:19 AM
Spoken like a true Uro recon.
November 19, 2024 at 11:41 AM
Let’s say Patient is wanting treatment and I agree with that. I was leaning toward RT due to risks of incontinence. But interesting to hear others thoughts.
November 18, 2024 at 10:48 PM
New diagnosis. On meds. Symptoms worrisome that he will have OAB and incontinence issues post surgery.
November 18, 2024 at 4:17 PM
Parkinson’s worries me for surgery?
November 18, 2024 at 3:32 PM
PSA is 8.7
November 18, 2024 at 2:29 PM
Cribiform glands present. 3+4 also on contralteral side. MRI c/w bilateral disease 1.4 cm and 1.0 cm. 40% pattern 4.

And for you, Matt he has a palpable lesion for cT2a and the GG2 larger lesion is also visible on US.
November 18, 2024 at 2:28 PM
Perhaps. This feels different. And the first I’ve looked into as a late adopter
November 17, 2024 at 5:05 PM